Differences by gender in metabolic dysfunction in patients with type 2 diabetes in first-level care.

Authors

Adriana L Valdez-González, Rita A Gómez-Díaz, Niels H Wacher-Rodarte

Published in

Gaceta medica de Mexico. Volume 162. Issue 1. Pages 73-80.

Abstract

The genotypic and phenotypic characteristics of men and women determine metabolic differences, given by hormonal mechanisms and sexual dimorphism in adipose tissue, impacting the health-disease process.
To compare the gender differences in metabolic alterations in patients with type 2 diabetes (T2DM) treated in first-level medical units.
Analytical transversal study. After signing informed consent, adult patients with T2DM were included. Sociodemographic, anthropometric, biochemical and clinical data were collected. Metabolic dysfunction was evaluated using metabolic syndrome criteria. They were analyzed using Student t, Pearson x² and Mann-Whitney U test to identify differences by gender.
5154 patients with DT2 were included. In women, a higher body mass index was observed (29.91 vs. 28.74 kg/m²; p < 0.001), and a higher proportion of obesity (44.2% vs. 38.7%; p < 0.001), hypercholesterolemia (94.0% vs. 90.5%; p < 0.001) and hypoalphalipoproteinemia (75.6% vs. 24.4%; p < 0.001), while microalbuminuria (36.4% vs 18.8%; p < 0.001) and hypertension (70.3% vs. 66.7%; p < 0.001) were higher in men.
The presence of metabolic dysfunction is different between women and men. Obesity, hypercholesterolemia and hypoalphalipoproteinemia were more frequent among women, while among men they were hypertension and the presence of microalbuminuria.

PMID:
42880761
Bibliographic data and abstract were imported from PubMed on 16 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.